000 | 01986 a2200541 4500 | ||
---|---|---|---|
005 | 20250517181900.0 | ||
264 | 0 | _c20190715 | |
008 | 201907s 0 0 eng d | ||
022 | _a1535-4989 | ||
024 | 7 |
_a10.1165/rcmb.2016-0379OC _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPhilp, Christopher J | |
245 | 0 | 0 |
_aExtracellular Matrix Cross-Linking Enhances Fibroblast Growth and Protects against Matrix Proteolysis in Lung Fibrosis. _h[electronic resource] |
260 |
_bAmerican journal of respiratory cell and molecular biology _c05 2018 |
||
300 |
_a594-603 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAirway Remodeling |
650 | 0 | 4 |
_aAmino Acid Oxidoreductases _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBleomycin |
650 | 0 | 4 | _aCell Adhesion |
650 | 0 | 4 | _aCell Proliferation |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCystamine _xpharmacology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aExtracellular Matrix _xmetabolism |
650 | 0 | 4 |
_aFibroblasts _xdrug effects |
650 | 0 | 4 |
_aGTP-Binding Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIdiopathic Pulmonary Fibrosis _xchemically induced |
650 | 0 | 4 |
_aLung _xdrug effects |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aProtein Glutamine gamma Glutamyltransferase 2 |
650 | 0 | 4 | _aProteolysis |
650 | 0 | 4 |
_aTransglutaminases _xantagonists & inhibitors |
700 | 1 | _aSiebeke, Ivonne | |
700 | 1 | _aClements, Debbie | |
700 | 1 | _aMiller, Suzanne | |
700 | 1 | _aHabgood, Anthony | |
700 | 1 | _aJohn, Alison E | |
700 | 1 | _aNavaratnam, Vidya | |
700 | 1 | _aHubbard, Richard B | |
700 | 1 | _aJenkins, Gisli | |
700 | 1 | _aJohnson, Simon R | |
773 | 0 |
_tAmerican journal of respiratory cell and molecular biology _gvol. 58 _gno. 5 _gp. 594-603 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1165/rcmb.2016-0379OC _zAvailable from publisher's website |
999 |
_c27705690 _d27705690 |